89bio shows its NASH hand, boosting FGF21 concept
Positive phase 2b results on liver fibrosis follow similar data with a rival drug from Akero.
Novartis pulls plug on landmark UK cholesterol trial
ORION-17 study has been abandoned, with Novartis opting instead for a smaller global trial.
Astellas GLOWing as Claudin drug aces gastric cancer trial
Pair of positive phase 3 studies means company will file for approval of zolbetuximab soon.
Rapid UTI tests could cut antibiotic resistance, says NICE
Rapid urine tests could help NHS ensure that antibiotics are used appropriately.
Open science: disrupting scientific community collaboration
The quiet rise of collaboration among pharma companies has never been more important.
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
Maximizing Insights At Congresses
In terms of gathering medical insights, congresses are unique for several reasons.
The Challenge Of Finding KOLs For Innovative Therapies
You have a truly innovative medicine with a unique proposition in an area with a clear unmet need
Social Health and Cancer as a Chronic Condition
Data demonstrates the critical role of social health for people living with and beyond cancer
Newel Health begins next phase of development of Soturi
Newel Health's Soturi, a DTx solution for Parkinson’s Disease, begins next phase.
4th Gene Therapy Analytical Development Europe Summit 2023
The definitive and only meeting focused on tackling challenges in gene therapy drug development